Indexat a

Llicència i ús

Citacions

Cited 7 times in

Cited 8 times in

Cited 5 times in

Altmetrics

Grant support

Hoffman-La Roche Ltd. supplied the reagent cobas (R) cfDNA Sample Preparation Kit for cfDNA extraction.

Anàlisi d'autories institucional

Compartir

Cell-free DNA concentration and fragment size fraction correlate with FDG PET/CT-derived parameters in NSCLC patients

Publicat a:European Journal Of Nuclear Medicine And Molecular Imaging. 48 (11): 3631-3642 - 2021-10-01 48(11), DOI: 10.1007/s00259-021-05306-2

Autors: Gonzalez de Aledo-Castillo, JM; Casanueva-Eliceiry, S; Soler-Perromat, A; Fuster, D; Pastor, V; Reguart, N; Vinolas, N; Reyes, R; Vollmer, I; Paredes, P; Puig-Butille, JA

Afiliacions

Resum

Purpose The aim of our study was to investigate the correlation between cfDNA concentration and fragment size fraction with FDG PET/CT- and CT-derived parameters in untreated NSCLC patient. Methods Fifty-three patients diagnosed of locally advanced or metastatic NSCLC who had undergone FDG PET/CT, CT and cfDNA analysis prior to any treatment were included in this retrospective study. CfDNA concentration was measured by fluorometry and fragment size fractions were determined by microchip electrophoresis. [F-18]F-FDG PET/CT was performed and standardised uptake values (SUV), metabolic tumour volume (MTV) and total lesion glycolysis (TLG) were calculated for primary, extrapulmonary and total disease. CT scans were evaluated according to RECIST 1.1 criteria. Results CfDNA concentration showed a positive correlation with extrapulmonary MTV (r(2) = 0.36, P = 0.009), and extrapulmonary TLG (r(2) = 0.35, P = 0.009) and their whole-body (wb) ratios. Higher concentrations of total cfDNA were found in patients with liver lesions. Short fragments of cfDNA (100-250 bp) showed a positive correlation with extrapulmonary MTV (r(2) = 0.49, P = 0.0005) and extrapulmonary TLG (r(2) = 0.39, P = 0.006) and their respective wb ratios, and a negative correlation with SUVmean (r(2) = -0.31, P = 0.03) and SUVmean/SUVmax ratio (r(2) = -0.34, P = 0.02). A higher fraction of short cfDNA fragments was found in patients with liver and pleural lesions. Conclusions This study supports the hypothesis that cfDNA concentration and short cfDNA fragment size fraction reflect the tumour burden as well as metabolic activity in advanced NSCLC patients. This suggests their suitability as complementary tests for a more accurate diagnosis of tumour metabolic behaviour and to allow personalised therapies.

Paraules clau